a developer of pharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that ABEO and AXON have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABEO and AXON's prices will move in lockstep.
Ticker / NAME | Correlation To ABEO | 1D Price Change % | ||
---|---|---|---|---|
ABEO | 100% | +1.25% | ||
AXON - ABEO | 31% Poorly correlated | +1.63% | ||
SCPH - ABEO | 29% Poorly correlated | -1.38% | ||
XNCR - ABEO | 29% Poorly correlated | +1.90% | ||
AMRN - ABEO | 28% Poorly correlated | +2.14% | ||
GLPG - ABEO | 28% Poorly correlated | +3.14% | ||
More |